APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Respiratory Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17392113038 January 2026196 pages

Choose your research edition.

Industry ResearchRespiratory Drug Delivery Devices Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Drug Delivery Devices Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Respiratory Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Drug Delivery Devices Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Respiratory Drug Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Respiratory Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Respiratory Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Respiratory Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Respiratory Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Respiratory Drug Delivery Devices include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Novartis, Teva, Organon, PARI GmbH and Omron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Respiratory Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Respiratory Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Respiratory Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Respiratory Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Respiratory Drug Delivery Devices Segment by Company

GSK

AstraZeneca

Chiesi

Boehringer Ingelheim

Novartis

Teva

Organon

PARI GmbH

Omron

Philips

Drive DeVilbiss Healthcare

Yuwell

Leyi

Folee

Beurer

Respiratory Drug Delivery Devices Segment by Type

Metered Dose Inhalers (MDI)

Dry Powder Inhalers (DPI)

Nebulizers

Respiratory Drug Delivery Devices Segment by Application

Asthma

COPD

Others

Respiratory Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Respiratory Drug Delivery Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Respiratory Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Respiratory Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Respiratory Drug Delivery Devices Industry Trends Table 2. Respiratory Drug Delivery Devices Industry Drivers Table 3. Respiratory Drug Delivery Devices Industry Opportunities and Challenges Table 4. Respiratory Drug Delivery Devices Industry Restraints Table 5. Global Respiratory Drug Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Respiratory Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Respiratory Drug Delivery Devices Sales by Manufacturers (M units) & (2021-2026) Table 8. Global Respiratory Drug Delivery Devices Sales Market Share by Manufacturers Table 9. Global Respiratory Drug Delivery Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Respiratory Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Respiratory Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Respiratory Drug Delivery Devices Manufacturers, Product Type & Application Table 13. Global Respiratory Drug Delivery Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Respiratory Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Metered Dose Inhalers (MDI) Table 17. Major Manufacturers of Dry Powder Inhalers (DPI) Table 18. Major Manufacturers of Nebulizers Table 19. Global Respiratory Drug Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (M units) Table 20. Global Respiratory Drug Delivery Devices Sales by Type (2021-2026) & (M units) Table 21. Global Respiratory Drug Delivery Devices Sales by Type (2027-2032) & (M units) Table 22. Global Respiratory Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 23. Global Respiratory Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 24. Global Respiratory Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (M units) Table 25. Global Respiratory Drug Delivery Devices Revenue by Type (2021-2026) & (M units) Table 26. Global Respiratory Drug Delivery Devices Revenue by Type (2027-2032) & (M units) Table 27. Global Respiratory Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 28. Global Respiratory Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Asthma Table 30. Major Manufacturers of COPD Table 31. Major Manufacturers of Others Table 32. Global Respiratory Drug Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (M units) Table 33. Global Respiratory Drug Delivery Devices Sales by Application (2021-2026) & (M units) Table 34. Global Respiratory Drug Delivery Devices Sales by Application (2027-2032) & (M units) Table 35. Global Respiratory Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 36. Global Respiratory Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 37. Global Respiratory Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (M units) Table 38. Global Respiratory Drug Delivery Devices Revenue by Application (2021-2026) & (M units) Table 39. Global Respiratory Drug Delivery Devices Revenue by Application (2027-2032) & (M units) Table 40. Global Respiratory Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 41. Global Respiratory Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 42. Global Respiratory Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (M units) Table 43. Global Respiratory Drug Delivery Devices Sales by Region (2021-2026) & (M units) Table 44. Global Respiratory Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 45. Global Respiratory Drug Delivery Devices Sales Forecasted by Region (2027-2032) & (M units) Table 46. Global Respiratory Drug Delivery Devices Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 48. North America Respiratory Drug Delivery Devices Sales by Country (2021-2026) & (M units) Table 49. North America Respiratory Drug Delivery Devices Sales by Country (2027-2032) & (M units) Table 50. Europe Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 51. Europe Respiratory Drug Delivery Devices Sales by Country (2021-2026) & (M units) Table 52. Europe Respiratory Drug Delivery Devices Sales by Country (2027-2032) & (M units) Table 53. Asia Pacific Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 54. Asia Pacific Respiratory Drug Delivery Devices Sales by Country (2021-2026) & (M units) Table 55. Asia Pacific Respiratory Drug Delivery Devices Sales by Country (2027-2032) & (M units) Table 56. South America, Middle East and Africa Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M units) Table 57. South America, Middle East and Africa Respiratory Drug Delivery Devices Sales by Country (2021-2026) & (M units) Table 58. South America, Middle East and Africa Respiratory Drug Delivery Devices Sales by Country (2027-2032) & (M units) Table 59. Global Respiratory Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Respiratory Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Respiratory Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Respiratory Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 63. Global Respiratory Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GSK Respiratory Drug Delivery Devices Product Portfolio Table 68. GSK Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. AstraZeneca Respiratory Drug Delivery Devices Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Chiesi Company Information Table 75. Chiesi Business Overview Table 76. Chiesi Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Chiesi Respiratory Drug Delivery Devices Product Portfolio Table 78. Chiesi Recent Development Table 79. Boehringer Ingelheim Company Information Table 80. Boehringer Ingelheim Business Overview Table 81. Boehringer Ingelheim Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Boehringer Ingelheim Respiratory Drug Delivery Devices Product Portfolio Table 83. Boehringer Ingelheim Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novartis Respiratory Drug Delivery Devices Product Portfolio Table 88. Novartis Recent Development Table 89. Teva Company Information Table 90. Teva Business Overview Table 91. Teva Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Teva Respiratory Drug Delivery Devices Product Portfolio Table 93. Teva Recent Development Table 94. Organon Company Information Table 95. Organon Business Overview Table 96. Organon Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Organon Respiratory Drug Delivery Devices Product Portfolio Table 98. Organon Recent Development Table 99. PARI GmbH Company Information Table 100. PARI GmbH Business Overview Table 101. PARI GmbH Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. PARI GmbH Respiratory Drug Delivery Devices Product Portfolio Table 103. PARI GmbH Recent Development Table 104. Omron Company Information Table 105. Omron Business Overview Table 106. Omron Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Omron Respiratory Drug Delivery Devices Product Portfolio Table 108. Omron Recent Development Table 109. Philips Company Information Table 110. Philips Business Overview Table 111. Philips Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Philips Respiratory Drug Delivery Devices Product Portfolio Table 113. Philips Recent Development Table 114. Drive DeVilbiss Healthcare Company Information Table 115. Drive DeVilbiss Healthcare Business Overview Table 116. Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Product Portfolio Table 118. Drive DeVilbiss Healthcare Recent Development Table 119. Yuwell Company Information Table 120. Yuwell Business Overview Table 121. Yuwell Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Yuwell Respiratory Drug Delivery Devices Product Portfolio Table 123. Yuwell Recent Development Table 124. Leyi Company Information Table 125. Leyi Business Overview Table 126. Leyi Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Leyi Respiratory Drug Delivery Devices Product Portfolio Table 128. Leyi Recent Development Table 129. Folee Company Information Table 130. Folee Business Overview Table 131. Folee Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Folee Respiratory Drug Delivery Devices Product Portfolio Table 133. Folee Recent Development Table 134. Beurer Company Information Table 135. Beurer Business Overview Table 136. Beurer Respiratory Drug Delivery Devices Sales (M units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Beurer Respiratory Drug Delivery Devices Product Portfolio Table 138. Beurer Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Respiratory Drug Delivery Devices Distributors List Table 142. Respiratory Drug Delivery Devices Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Respiratory Drug Delivery Devices Product Image Figure 2. Global Respiratory Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Drug Delivery Devices Sales (2021-2032) & (M units) Figure 5. Global Respiratory Drug Delivery Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Respiratory Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Metered Dose Inhalers (MDI) Image Figure 9. Dry Powder Inhalers (DPI) Image Figure 10. Nebulizers Image Figure 11. Global Respiratory Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (M units) Figure 12. Global Respiratory Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Respiratory Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 14. Global Respiratory Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (M units) Figure 15. Global Respiratory Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Respiratory Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 17. Asthma Image Figure 18. COPD Image Figure 19. Others Image Figure 20. Global Respiratory Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (M units) Figure 21. Global Respiratory Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Respiratory Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 23. Global Respiratory Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (M units) Figure 24. Global Respiratory Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Respiratory Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 26. North America Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 27. North America Respiratory Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 28. U.S. Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 29. Canada Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 30. Mexico Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 31. Europe Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 32. Europe Respiratory Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 33. Germany Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 34. France Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 35. U.K. Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 36. Italy Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 37. Netherlands Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 38. Asia Pacific Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 39. Asia Pacific Respiratory Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 40. China Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 41. Japan Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 42. South Korea Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 43. Southeast Asia Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 44. India Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 45. Australia Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 46. South America, Middle East and Africa Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 47. South America, Middle East and Africa Respiratory Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 48. Brazil Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 49. South Africa Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 50. Saudi Arabia Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 51. Turkey Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 52. Argentina Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 53. UAE Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 54. Egypt Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 55. Chile Respiratory Drug Delivery Devices Sales and Growth Rate (2021-2032) & (M units) Figure 56. Global Respiratory Drug Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Respiratory Drug Delivery Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Respiratory Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 59. North America Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Respiratory Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 61. Europe Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Respiratory Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Respiratory Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Respiratory Drug Delivery Devices Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Respiratory Drug Delivery Devices Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Metered Dose Inhalers (MDI)
  • Dry Powder Inhalers (DPI)
  • Nebulizers
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GSK
  • AstraZeneca
  • Chiesi
  • Boehringer Ingelheim
  • Novartis
  • Teva
  • Organon
  • PARI GmbH
  • Omron
  • Philips
  • Drive DeVilbiss Healthcare
  • Yuwell
  • Leyi
  • Folee
  • Beurer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Respiratory Drug Delivery Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Respiratory Drug Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Respiratory Drug Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Respiratory Drug Delivery Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Respiratory Drug Delivery Devices Market Dynamics
  1. 2.1 Respiratory Drug Delivery Devices Industry Trends
  2. 2.2 Respiratory Drug Delivery Devices Industry Drivers
  3. 2.3 Respiratory Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Respiratory Drug Delivery Devices Industry Restraints
3 Respiratory Drug Delivery Devices Market by Manufacturers
  1. 3.1 Global Respiratory Drug Delivery Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Respiratory Drug Delivery Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Respiratory Drug Delivery Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Respiratory Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Respiratory Drug Delivery Devices Manufacturers, Product Type & Application
  7. 3.7 Global Respiratory Drug Delivery Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Drug Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Drug Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Drug Delivery Devices Tier 1, Tier 2, and Tier 3
4 Respiratory Drug Delivery Devices Market by Type
  1. 4.1 Respiratory Drug Delivery Devices Type Introduction
  2. 4.1.1 Metered Dose Inhalers (MDI)
  3. 4.1.2 Dry Powder Inhalers (DPI)
  4. 4.1.3 Nebulizers
  5. 4.2 Global Respiratory Drug Delivery Devices Sales by Type
  6. 4.2.1 Global Respiratory Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Respiratory Drug Delivery Devices Sales by Type (2021-2032)
  8. 4.2.3 Global Respiratory Drug Delivery Devices Sales Market Share by Type (2021-2032)
  9. 4.3 Global Respiratory Drug Delivery Devices Revenue by Type
  10. 4.3.1 Global Respiratory Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Respiratory Drug Delivery Devices Revenue by Type (2021-2032)
  12. 4.3.3 Global Respiratory Drug Delivery Devices Revenue Market Share by Type (2021-2032)
5 Respiratory Drug Delivery Devices Market by Application
  1. 5.1 Respiratory Drug Delivery Devices Application Introduction
  2. 5.1.1 Asthma
  3. 5.1.2 COPD
  4. 5.1.3 Others
  5. 5.2 Global Respiratory Drug Delivery Devices Sales by Application
  6. 5.2.1 Global Respiratory Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Respiratory Drug Delivery Devices Sales by Application (2021-2032)
  8. 5.2.3 Global Respiratory Drug Delivery Devices Sales Market Share by Application (2021-2032)
  9. 5.3 Global Respiratory Drug Delivery Devices Revenue by Application
  10. 5.3.1 Global Respiratory Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Respiratory Drug Delivery Devices Revenue by Application (2021-2032)
  12. 5.3.3 Global Respiratory Drug Delivery Devices Revenue Market Share by Application (2021-2032)
6 Global Respiratory Drug Delivery Devices Sales by Region
  1. 6.1 Global Respiratory Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Respiratory Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Respiratory Drug Delivery Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Respiratory Drug Delivery Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Respiratory Drug Delivery Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Respiratory Drug Delivery Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Respiratory Drug Delivery Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Respiratory Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Respiratory Drug Delivery Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Respiratory Drug Delivery Devices Revenue by Region
  1. 7.1 Global Respiratory Drug Delivery Devices Revenue by Region
  2. 7.1.1 Global Respiratory Drug Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Respiratory Drug Delivery Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Respiratory Drug Delivery Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Respiratory Drug Delivery Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Respiratory Drug Delivery Devices Revenue (2021-2032)
  8. 7.2.2 North America Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Respiratory Drug Delivery Devices Revenue (2021-2032)
  11. 7.3.2 Europe Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Respiratory Drug Delivery Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Respiratory Drug Delivery Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Respiratory Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Respiratory Drug Delivery Devices Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Respiratory Drug Delivery Devices Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Chiesi
  14. 8.3.1 Chiesi Company Information
  15. 8.3.2 Chiesi Business Overview
  16. 8.3.3 Chiesi Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiesi Respiratory Drug Delivery Devices Product Portfolio
  18. 8.3.5 Chiesi Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Respiratory Drug Delivery Devices Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Respiratory Drug Delivery Devices Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Teva
  32. 8.6.1 Teva Company Information
  33. 8.6.2 Teva Business Overview
  34. 8.6.3 Teva Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Respiratory Drug Delivery Devices Product Portfolio
  36. 8.6.5 Teva Recent Developments
  37. 8.7 Organon
  38. 8.7.1 Organon Company Information
  39. 8.7.2 Organon Business Overview
  40. 8.7.3 Organon Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Organon Respiratory Drug Delivery Devices Product Portfolio
  42. 8.7.5 Organon Recent Developments
  43. 8.8 PARI GmbH
  44. 8.8.1 PARI GmbH Company Information
  45. 8.8.2 PARI GmbH Business Overview
  46. 8.8.3 PARI GmbH Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PARI GmbH Respiratory Drug Delivery Devices Product Portfolio
  48. 8.8.5 PARI GmbH Recent Developments
  49. 8.9 Omron
  50. 8.9.1 Omron Company Information
  51. 8.9.2 Omron Business Overview
  52. 8.9.3 Omron Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Omron Respiratory Drug Delivery Devices Product Portfolio
  54. 8.9.5 Omron Recent Developments
  55. 8.10 Philips
  56. 8.10.1 Philips Company Information
  57. 8.10.2 Philips Business Overview
  58. 8.10.3 Philips Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Philips Respiratory Drug Delivery Devices Product Portfolio
  60. 8.10.5 Philips Recent Developments
  61. 8.11 Drive DeVilbiss Healthcare
  62. 8.11.1 Drive DeVilbiss Healthcare Company Information
  63. 8.11.2 Drive DeVilbiss Healthcare Business Overview
  64. 8.11.3 Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Drive DeVilbiss Healthcare Respiratory Drug Delivery Devices Product Portfolio
  66. 8.11.5 Drive DeVilbiss Healthcare Recent Developments
  67. 8.12 Yuwell
  68. 8.12.1 Yuwell Company Information
  69. 8.12.2 Yuwell Business Overview
  70. 8.12.3 Yuwell Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yuwell Respiratory Drug Delivery Devices Product Portfolio
  72. 8.12.5 Yuwell Recent Developments
  73. 8.13 Leyi
  74. 8.13.1 Leyi Company Information
  75. 8.13.2 Leyi Business Overview
  76. 8.13.3 Leyi Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Leyi Respiratory Drug Delivery Devices Product Portfolio
  78. 8.13.5 Leyi Recent Developments
  79. 8.14 Folee
  80. 8.14.1 Folee Company Information
  81. 8.14.2 Folee Business Overview
  82. 8.14.3 Folee Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Folee Respiratory Drug Delivery Devices Product Portfolio
  84. 8.14.5 Folee Recent Developments
  85. 8.15 Beurer
  86. 8.15.1 Beurer Company Information
  87. 8.15.2 Beurer Business Overview
  88. 8.15.3 Beurer Respiratory Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Beurer Respiratory Drug Delivery Devices Product Portfolio
  90. 8.15.5 Beurer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Respiratory Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Respiratory Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Respiratory Drug Delivery Devices Production Mode & Process
  6. 9.2 Respiratory Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Respiratory Drug Delivery Devices Distributors
  9. 9.2.3 Respiratory Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst